3-Bromo-4-fluorobenzoic Acid is a building block used in the synthesis of a highly selective and potent PTP-MEG2 inhibitor with therapeutic potential for type 2 diabetes.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.